Prevalence of Gastroesophageal Reflux Disease in Peritoneal Dialysis and Hemodialysis Patients

Overview

The purpose of this study is to determine the prevalence of GERD among chronic kidney disease with peritoneal dialysis and hemodialysis in Korea.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 2012

Detailed Description

Gastroesophageal reflux disease is a common upper gastrointestinal disorder in chronic kidney disease. But, little is known about the prevalence in dialysis patients. The aims of this study were to determine the prevalence of GERD among chronic kidney disease with peritoneal dialysis and hemodialysis in Korea.

Arms, Groups and Cohorts

  • hemodialysis patients
  • Peritoneal dialysis patients

Clinical Trial Outcome Measures

Primary Measures

  • prevalence of GERD among chronic kidney disease with peritoneal dialysis and hemodialysis
    • Time Frame: 2 yrs

Secondary Measures

  • risk factor for GERD in peritoneal dialysis and hemodialysis patients
    • Time Frame: 2 yrs

Participating in This Clinical Trial

Inclusion Criteria

  • peritoneal dialysis and hemodialysis patients Exclusion Criteria:

  • a history of abdominal surgery or with a proton pump inhibitor before 1 month and a eradication of H. pylori were excluded

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Song Kyung Ho
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Song Kyung Ho, assistant professor – Konyang University Hospital
  • Overall Official(s)
    • Hyun jung Song, Bechelor’s, Principal Investigator, Konyang University Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.